Bank of America
CPHR

Bank of America’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Bank of America’s Portfolio CPHR Stock Details CPHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,903
Closed -$10K – 7581
2016
Q2 		$10K Buy
+1,903
New +$10.8K ﹤0.01% 6516
2016
Q1 		– Sell
-800
Closed -$4K – 7613
2015
Q4 		$4K Buy
800
+733
+1,094% +$3.17K ﹤0.01% 6983
2015
Q3 		$0 Sell
67
-733
-92% -$5.09K ﹤0.01% 7629
2015
Q2 		$7K Sell
800
-3,300
-80% -$32.9K ﹤0.01% 6732
2015
Q1 		$37K Buy
4,100
+3,900
+1,950% +$49K ﹤0.01% 5796
2014
Q4 		$3K Buy
+200
New +$2.9K ﹤0.01% 7443

Other funds holding CPHR

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's CPHR Position: Q3 2016 in Review

Bank of America sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q3 2016, closing a stake of 1,903 shares — an estimated $10K sold.

Bank of America first reported a position in CPHR in Q4 2014 and held it in 6 quarters. The position peaked at $37K in Q1 2015. 18 funds tracked by Wall St. Rank hold CPHR as of Q3 2016.

  • Bank of America reported no remaining Cipher Pharmaceuticals Inc. position as of Q3 2016 after selling out during the quarter.
  • Bank of America sold 1,903 Cipher Pharmaceuticals Inc. shares in Q3 2016, an estimated $10K.
  • Bank of America first reported a position in Cipher Pharmaceuticals Inc. in Q4 2014 and held it in 6 quarters.
  • Bank of America's Cipher Pharmaceuticals Inc. position peaked at $37K in Q1 2015.
  • 18 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q3 2016.

Based on Bank of America's 13F filing for Q3 2016, filed 14 Nov 2016.